Signet-Ring Cell/Histiocytoid Carcinoma: Report of Two Cases and Systematic Review of the Literature on the Epidemiology, Clinical Characteristics, and Pathological and Molecular Findings

Am J Dermatopathol. 2023 Sep 1;45(9):626-630. doi: 10.1097/DAD.0000000000002495. Epub 2023 Jul 28.

Abstract

Signet-ring cell/histiocytoid carcinoma (SRCHC) is a rare appendageal tumor, mainly considering eyelids, more rarely axillae. This article describes 2 novel SRCHC cases of 71- and 66-year-old men and systematically reviews the literature on SRCHC. Of all cases reported in the literature, 73 (91.2%) were men and 7 (8.8%) were women. The median age at diagnosis was 71 years. Skin changes were located in the eyelids (68%) and axillae (32%). In all tested cases, SRCHC cells expressed CK7, CKAE1/AE3, EMA, CAM5.2, and AR and PIK3CA mutations. Future research should determine whether AR/PIK3CA-targeted therapies influence patients' survival.

Publication types

  • Systematic Review
  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Signet Ring Cell* / epidemiology
  • Carcinoma, Signet Ring Cell* / genetics
  • Eyelid Neoplasms* / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Skin / pathology
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / pathology